Medical technology company Sterifre Medical Inc said on Thursday that it has developed technology to help fight the spread of COVID-19 and other contagious pathogens.
The AURA system enables fast and automated device disinfection at the point of care. It can be used on medical equipment such as thermometers, glucometers, otoscopes, stethoscopes, oximeters, pads/sensors, cords/cables and doppler probes and can also disinfect radios, phones, tablets, remote controls and call buttons as well as phones, keys, ID badges and jewellery.
The company said it is working at the state and federal level to expedite the approval process for the AURA system.
Sterifre is working to obtain an expedited registration with the US Environmental Protection Agency (EPA), which regulates microbicides used for hospital disinfection. It is also seeking EPA approval under the Emerging Viral Pathogens Program for inactivating SARS-CoV-2, the virus that causes COVID-19.
Since the only byproduct of AURA is clean air, the system can be used at the patient's bedside. It can also be placed on a countertop at the nurse's station, in a utility room or stowed on a cart or a wall so it's readily available. The unit can be rapidly deployed, needing only an electrical outlet and with no plumbing connection required.
Currently, there are only a small number of specialty wipe manufacturers in the US and only a handful of brands are approved by the EPA for coronavirus in the healthcare setting, making shortages more prevalent.
Saluda Medical secures CE certification for EVA Sensing Technology in Europe
Antin to acquire clinical trial equipment provider Emsere
Hyphens Pharma licenses Cerapro skin cream to Louis Widmer for six European markets
Profusa signs French distributor to expand Lumee Oxygen rollout in Europe
Sensiva Health names new chief operating officer
BrioHealth Solutions enrols 100th participant in BrioVAD System trial
Abbott's Amplatzer Piccolo Delivery System receives US FDA clearance and CE Mark
Amphix Bio announces initial closing of USD12.5m seed financing round
Bioretec wins FDA breakthrough status for biodegradable orthopaedic DrillPin
Amferia raises EUR3.5m to advance antimicrobial wound-care platform
BioCryst wins FDA approval for oral HAE prophylaxis in young children
ALR Technologies announces GluCurve Pet CGM relaunch in Canada
Galderma secures EU MDR certification for Sculptra, expanding use to multiple body areas
Clinical Laserthermia Systems applies for CE marking of ClearPoint Prism neuro laser system